Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis (Q33815049)

29 July 2017

1 reference

title

Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis (English)

1 reference

29 July 2017

1 reference

Suzuki Y

1

1 reference

29 July 2017

publication date

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

201

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

255-271

1 reference

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Toxoplasmic encephalitis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Interferon-gamma: the major mediator of resistance against Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Studies on experimental toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Murine model of intracerebral toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Polymorphisms in the tumor necrosis factor alpha (TNF-alpha) gene correlate with murine resistance to development of toxoplasmic encephalitis and with levels of TNF-alpha mRNA in infected brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Different roles for interleukin-4 during the course of Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Interleukin-6 in biology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Transforming growth factor beta: a matter of life and death

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Functional dichotomy of mouse microglia developed in vitro: differential effects of macrophage and granulocyte/macrophage colony-stimulating factor on cytokine secretion and antitoxoplasmic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Differences in virulence and development of encephalitis during chronic infection vary with the strain of Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Virulent strains of Toxoplasma gondii comprise a single clonal lineage

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Toxoplasma gondii Comprises Three Clonal Lineages: Correlation of Parasite Genotype with Human Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

Enhanced endothelial cell adhesion of human cerebrospinal fluid lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980066-7

7 January 2021

10.1016/S0171-2985(99)80066-7

Identifiers

DOI

0 references

1 reference